Vaccination responses and lymphocyte subsets after autologous stem cell transplantation

Vaccine

Volumn 25, Issue 51, 2007, Pages 8512-8517

  van der Velden, A M T ^a,b   Claessen, A M E ^a   van Velzen Blad, H ^a   de Groot, M R ^c   Kramer, M H H ^d   Biesma, D H ^a   Rijkers, G T ^a,e  

^a ST ANTONIUS HOSPITAL   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c MEDISCH SPECTRUM TWENTE   (Netherlands)

^d MEANDER MEDICAL CENTER   (Netherlands)

^e UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Autologous stem cell transplantation; Lymphocyte subsets; Vaccination

Indexed keywords

7 VALENT PNEUMOCOCCAL VACCINE; CD19 ANTIGEN; CONJUGATE VACCINE; DIPHTHERIA POLIOMYELITIS TETANUS VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; IMMUNOGLOBULIN G ANTIBODY; PNEUMOCOCCUS VACCINE; POLYSACCHARIDE VACCINE; TETANUS ANTIBODY; UNCLASSIFIED DRUG; VACCINE;

ADULT; AGED; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; B LYMPHOCYTE; CD16+CD56+ CELL; CD19+ B LYMPHOCYTE; CELL COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GRAFT RECIPIENT; HUMAN; IMMUNE RESPONSE; INFECTION COMPLICATION; LYMPHOCYTE SUBPOPULATION; MALE; NATURAL KILLER CELL; PRIORITY JOURNAL; T LYMPHOCYTE; TREATMENT RESPONSE; VACCINATION;

ADULT; AGED; AMYLOIDOSIS; ANTIBODIES; B-LYMPHOCYTE SUBSETS; DIPHTHERIA-TETANUS-PERTUSSIS VACCINE; FEMALE; FOLLOW-UP STUDIES; HAEMOPHILUS INFLUENZAE TYPE B; HAEMOPHILUS VACCINES; HUMANS; IMMUNIZATION SCHEDULE; IMMUNOGLOBULIN G; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; MULTIPLE MYELOMA; PHENOTYPE; PROSPECTIVE STUDIES; STEM CELL TRANSPLANTATION; TRANSPLANTATION, AUTOLOGOUS; VACCINATION; VACCINES, CONJUGATE;

EID: 36549002664     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.10.008     Document Type: Article

References (25)

1. Harousseau J.L., and Moreau P. Evolving role of stem cell transplantation in multiple myeloma. Clin Lymphoma Myeloma 6 (2005) 89-95
2. Lossos I.S., Breuer R., Or R., Strauss N., Elishoov H., Naparstek E., et al. Bacterial pneumonia in recipients of bone marrow transplantation. A five-year prospective study. Transplantation 60 (1995) 672-678
3. Frere P., Pereira M., Fillet G., and Beguin Y. Infections after CD34-selected or unmanipulated autologous hematopoietic stem cell transplantation. Eur J Haematol 76 (2006) 102-108
4. Centers for Disease Control Prevention. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients: recommendations of CDC, the Infectious Disease Society of America, and the American Society of Blood and Marrow Transplantation. MMWR 49 (2000) RR-10
5. Ljungman P., Engelhard D., de la Cámara R., Einsele H., Locasciulli A., Martino R., et al. Vaccination of stem cell transplant recipients: recommendations of the Infectious Diseases Working Party of the EBMT. BMT 35 (2005) 737-746
6. Sullivan K.M., Dykewicz C.A., Longworth D.L., Boeckh M., Baden L.R., Rubin R., et al. Preventing opportunistic infections after hematopoietic stem cell transplantation: the Centers for Disease Control and Prevention, Infectious Diseases Society of America, and American Society for Blood and Marrow Transplantation Practice Guidelines and beyond. Hematology (Am. Soc. Hematol. Educ. Program.) (2001) 392-421
7. Vance E., George S., Guinan E.C., Wheeler C., Antin J.H., Ambrosino D.M., et al. Comparison of multiple immunization schedules for Haemophilus influenzae type b-conjugate and tetanus toxoid vaccines following bone marrow transplantation. Bone Marrow Transplant 22 (1998) 735-741
8. Robertson J.D., Nagesh K., Jowitt S.N., Dougal M., Anderson H., Mutton K., et al. Immunogenicity of vaccination against influenza, Streptococcus pneumoniae and Haemophilus influenzae type B in patients with multiple myeloma. Br J Cancer 82 (2000) 1261-1265
9. Antin J.H., Guinan E.C., Avignan D., Soiffer R.J., Joyce R.M., Martin V.J., et al. Protective antibody responses to pneumococcal conjugate vaccine after autologous hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 11 (2005) 213-222
10. Zielen S., Buhring I., Strnad N., Reichenbach J., and Hofmann D. Immunogenicity and tolerance of a 7-valent pneumococcal conjugate vaccine in nonresponders to the 23-valent pneumococcal vaccine. Infect Immun 68 (2000) 1435-1440
11. Molldrem J.J. Vaccinating transplant recipients. Nat Med 11 (2005) 1162-1163
12. Porrata L.F., Litzow M.R., and Markovic S.N. Immune reconstitution after autologous hematopoietic stem cell transplantation. Mayo Clin Proc 76 (2001) 407-412
13. Guillaume T., Rubinstein D.B., and Symann M. Immune reconstitution after autologous hematopoietic stem cell transplantation. Blood 92 (1998) 1471-1490
14. Douek D.C., Vescio R.A., Betts M.R., Brenchley J.M., Hill B.J., and Zhang L. Assessment of thymic output in adults after haematopoietic stem cell transplantation and prediction of T-cell reconstitution. Lancet 355 (2000) 1875-1881
15. Siber G.R., Ambrosino D.M., McIver J., Ervin T.J., Schiffman G., Sallan S., et al. Preparation of human hyperimmune globulin to Haemophilus influenza b, Streptococcus pneumoniae, and Neisseria meningitidis. Infect Immun 45 (1984) 248-254
16. Jol-van der Zijde C.M., van der Kaaden M., Rumke H.C., Gerritsen E.J.A., Vossen J.M., and van Tol M.J. The antibody response against tetanus toxoid: a longitudinal study in healthy infants and adults. In: Chapel H.M., Levinsky R.J., and Webster A.D.B. (Eds). Progress in immunodeficiency III (1991), Royal Society of Medicine Services Ltd., London 238-240
17. Goldblatt D., Vaz A.R., and Miller E. Antibody avidity as a surrogate marker of successful priming by Haemophilus influenzae type b conjugate vaccines following infant immunization. J Infect Dis 177 (1998) 1112-1115
18. Hartkamp A., Mulder A.H., Rijkers G.T., van Velzen-Blad H., and Biesma D.H. Antibody responses to pneumococcal and haemophilus vaccinations in patients with B-cell chronic lymphocytic leukaemia. Vaccine 19 (2001) 1671-1677
19. De Vries E., de Bruin-Versteeg S., Comans-Bitter W.M., de Groot R., Hop W.C.J., Boerma G.J.M., et al. Longitudinal survey of lymphocyte subpopulations in the first year of life. Pediatr Res 47 (2000) 528-537
20. Bogaert D., Hermans P.W., Adrian P.V., Rumke H.C., and de Groot R. Pneumococcal vaccines: an update on current strategies. Vaccine 22 (2004) 2209-2220
21. Rose M.A., Schubert R., Strnad N., and Zielen S. Priming of immunological memory by pneumococcal conjugate vaccine in children unresponsive to 23-valent pneumococcal vaccine. Clin Diagn Lab Immunol 12 (2005) 1216-1222
22. Molrine D.C., George S., Tarbell N., Mauch P., Diller L., Neuberg D., et al. Antibody responses to polysaccharide and polysaccharide-conjugate vaccines after treatment of Hodgkin disease. Ann Intern Med 123 (1995) 828-834
23. Butler J.C., Breiman R.F., Campbell J.F., Lipman H.B., Broome C.V., and Facklam R.R. Pneumococcal polysaccharide vaccine efficacy. An evaluation of current recommendations. JAMA 270 (1993) 1826-1831
24. Koehne G., Zeller W., Stockschlaeder M., and Zander A.R. Phenotype of lymphocyte subsets after autologous peripheral blood stem cell transplantation. BMT 19 (1997) 149-156
25. Rapoport A.P., Stadtmauer E.A., Aqui N., Badros A., Cotte J., Chrisley L., et al. Restoration of immunity in lymphopenic individuals with cancer by vaccination and adoptive T-cell transfer. Nature Med 11 (2005) 1230-1237